ADAM S GARDEN to Radiation-Sensitizing Agents
This is a "connection" page, showing publications ADAM S GARDEN has written about Radiation-Sensitizing Agents.
Connection Strength
0.381
-
Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14). Int J Radiat Oncol Biol Phys. 2008 Aug 01; 71(5):1351-5.
Score: 0.264
-
Development of investigational radiation modifiers. J Natl Cancer Inst. 2003 May 07; 95(9):646-51.
Score: 0.092
-
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol. 2014 Sep 20; 32(27):2940-50.
Score: 0.025